Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001399241 | SCV001601026 | likely benign | Dilated cardiomyopathy 1DD | 2023-12-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003343665 | SCV004058439 | benign | Cardiovascular phenotype | 2023-06-29 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV004724942 | SCV005332038 | uncertain significance | not provided | 2023-05-21 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 29420653) |
Blueprint Genetics | RCV000157432 | SCV000207176 | uncertain significance | Primary familial hypertrophic cardiomyopathy | 2014-06-11 | no assertion criteria provided | clinical testing |